Intlekofer, A. M., & Thompson, C. B. (2013). At the Bench: Preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy. Society for Leukocyte Biology.
Citação norma ChicagoIntlekofer, Andrew M., and Craig B. Thompson. At the Bench: Preclinical Rationale for CTLA-4 and PD-1 Blockade As Cancer Immunotherapy. Society for Leukocyte Biology, 2013.
Citação norma MLAIntlekofer, Andrew M., and Craig B. Thompson. At the Bench: Preclinical Rationale for CTLA-4 and PD-1 Blockade As Cancer Immunotherapy. Society for Leukocyte Biology, 2013.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.